Wichtige Neuerungen in der WHO-Klassifikation der ZNS-Tumoren mit neuroradiologischer Relevanz

Die 5. Edition der WHO-Klassifikation der ZNS-Tumoren beinhaltet viele neue Aspekte, vor allem zu den molekularen Kriterien der Diagnostik. Einige Neuerungen muss auch der Neuroradiologe im Rahmen der Routinediagnostik kennen, z. B. die geänderten Kriterien der Tumorgraduierung oder auch die Tatsache, dass bei bestimmten Tumoren mit molekular bestätigtem Tumorgrad 4 die bildgebenden Merkmale eines hochgradigen Tumors im Einzelfall fehlen können.

• Literatur

• 1 Brat DJ, Ellison DW, Figarella-Branger D. et al. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 2 Brat DJ, Ellison DW, Figarella-Branger D. et al. Gliomas, glioneuronal Tumours, and neuronal Tumours. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 3 Nafe R, Porto L, Samp PF. et al. Adult-type and pediatric-type diffuse gliomas – what the neuroradiologist should know. Clin Neuroradiol 2023;
• 4 Sabin ND, Hwang SN, Klimo P. et al. Anatomic neuroimaging characteristics of posterior fossa type A ependymoma subgroups. Am J Neuroradiol 2021; 42: 2245-2250
• 5 Bender K, Perez E, Chirica M. et al. High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity. J Neurooncol 2021; 153: 109-120
• 6 Chen W, Soon YY, Pratiseyo PD. et al. Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases. Brain Tumor Pathol 2020; 37: 145-153
• 7 Solomon DA, Blümcke I, Gessi M. et al. Myxoid glioneuronal Tumour. In: WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 8 Jarzembowski JA, De Kock L, Mete O. et al. Pituitary Blastoma. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 9 Singh R, Wesseling P. Melanocytic Tumours. WHO Classification of Tumours Editorial Board. Central nervous system tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 10 Griewank KG, Koelsche C, Van de Nes J. et al. Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profiling. Clin Cancer Res 2018; 24: 4494-4504
• 11 Asa SL, Mete O. Immunohistochemical biomarkers in pituitary pathology. Endocr Pathol 2018; 29: 130-136
• 12 Ellison DW, Figarella-Branger D, Pfister SM. et al. Embryonal tumours. WHO Classification of Tumours Editorial Board. Central nervous system tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 13 Sharma T, Schwalbe EC, Williamson D. et al. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 2019; 138: 309-326
• 14 Lastowska M, Trubicka J, Sobocinska A. et al. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes. Acta Neuropathol Commun 2020; 8: 105
• 15 Ferris SP, Vega JV, Aboian M. et al. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathol 2020; 30: 46-62
• 16 Lazar AJ, Ng HK. Mesenchymal, non-meningothelial Tumours involving the CNS. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 17 Yang MJ, Whelan R, Madden J. et al. Intracranial Ewing sarcoma: four pediatric examples. Childs Nerv Syst 2018; 34: 441-448
• 18 Louis DN. Meningioma. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 19 Jiang J, Yu J, Liu X. et al. The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion. Front Oncol 2023; 12: 1100350
• 20 Hasselblatt M, Huang A, Jones DTW. et al. Pineocytoma. WHO Classification of Tumours Editorial Board. Central nervous System Tumours. (WHO classification of tumours series, 5th ed.; vol. 6). Lyon (France): International Agency for Research on Cancer; 2021. https://publications.iarc.fr/601
• 21 Liu APY, Bryan KL, Pfaff E. et al. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol 2021; 141: 771-785
• 22 Vasiljevic A. Histopathology and molecular pathology of pediatric pineal parenchymal tumors. Childs Nerv Syst 2022;
• 23 Komakula S, Warmuth-Metz M, Hildenbrand P. et al. Pineal parenchymal tumor of intermediate differentiation: Imaging spectrum of an unusual tumor in 11 cases. Neuroradiology 2011; 53: 577-584